It is known that a diagnosis of ovarian, fallopian tube, peritoneal or endometrial cancer may be the first indicator of a BRCA1 or BRCA2 mutation or Lynch Syndrome due to germline mutations in one of the mismatch repair genes: MLH1, MSH2, MSH6 or PMS2 [1, 2]. Here, BRCA1 is linked to Lynch syndrome.